Brigit Biofarmaka Teknologi Tbk. vs Surya Pertiwi Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Surya Pertiwi Tbk. trades at Rp605 (market cap 1.65T, 165.9K 24h volume). The key difference: Surya Pertiwi Tbk. is far larger — about 10× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Surya Pertiwi Tbk. is more actively traded (165.9K versus 62.5K). Which is the better fit depends on your goals.
| OBAT | SPTO | |
|---|---|---|
Market Cap | 164.65B | 1.65T |
Volume | 62.5K | 165.9K |
Lot | 625 | 1.66K |
Turnover | 15.03M | 100.31M |
Average Price | 240.55 | 604.61 |
Value | 15.03M | 100.31M |
Indicative Equilibrium Price | 238 | 605 |
Indicative Equilibrium Volume | 100 | 74 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Surya Pertiwi Tbk (the Company) formerly PT Surya Nusantara was established in the Republic of Indonesia on July 5, 1978 and was published in State Gazette No. 172, Supplement No. 31 dated April 17, 1979 based on Notarial Deed No. 1 of Hendra Karyadi, S.H.
Read more on SPTO →